InsiderClue
← All stocks

Guardant Health, Inc.

GH Net selling
CIK 0001576280 #681 in the set updated 17 Sep 2026
Bought (12 mo)
$78.46K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$171.20M
$34.54M on a plan · $85.98M straight out of an exercise
Sold at will
$50.68M
44 of 139 sales
Net
−$171.13M
−$50.61M against sales at will

By person

18 insiders · 140 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Talasaz AmirAli
Co-Chief Executive Officer
—
$84.25M (28) scheduled
−$84.25M
2,050,957
1.53%
$324.15M
−20.2%
Eltoukhy Helmy
Co-Chief Executive Officer
—
$22.03M (9)
−$22.03M
4,003,660
2.98%
$632.77M
−6.9%
Freeman Chris
Chief Commercial Officer
—
$16.92M (16) scheduled
−$16.92M
65,374
0.0487%
$10.33M
+136.1%
Monroe Terilyn J.
Chief People Officer
—
$15.95M (19) scheduled
−$15.95M
22,979
0.0171%
$3.63M
+1,198%
Bell Michael Brian
Chief Financial Officer
—
$8.81M (14) scheduled
−$8.81M
51,816
0.0386%
$8.19M
+158.7%
CLARK IAN T
Director
—
$6.06M (6) scheduled
−$6.06M
2,975
0.0022%
$470.19K
−81.0%
Kalia Kumud
Chief Information Officer
$78.46K (1)
$5.91M (8) scheduled
−$5.83M
39,794
0.0297%
$6.29M
+73.3%
Saia John G.
Chief Legal Officer
—
$4.25M (6) scheduled
−$4.25M
38,991
0.0291%
$6.16M
+33.4%
Chudova Darya
Chief Technology Officer
—
$2.99M (3)
−$2.99M
132,853
0.0990%
$21.00M
+48.5%
Joyce Meghan V.
Director
—
$1.27M (4) scheduled
−$1.27M
15,386
0.0115%
$2.43M
+47.8%
Krognes Steve E.
Director
—
$1.23M (1)
−$1.23M
14,580
0.0109%
$2.30M
+51.8%
Hidalgo Medina Manuel
Director
—
$936.15K (11) scheduled
−$936.15K
4,788
0.0036%
$756.74K
—
Tariq Musa
Director
—
$396.87K (11) scheduled
−$396.87K
11,316
0.0084%
$1.79M
+151.7%
POTTER MYRTLE S
Director
—
$207.27K (3) scheduled
−$207.27K
20,971
0.0156%
$3.31M
+55.2%
EAGLE CRAIG
Chief Medical Officer
—
—
—
72,001
0.0537%
$11.38M
+275.3%
Gadde Vijaya
Director
—
—
—
28,517
0.0213%
$4.51M
+61.7%
MIGNONE ROBERTO
Director
—
—
—
10,010
0.0075%
$1.58M
—
Azar Alex M II
Director
—
—
—
1,651
0.0012%
$260.94K
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 172
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 39
Sales straight out of an exercise 56
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 3,230,312
History held since 11 Oct 2018